Multi-omics and single-cell sequencing analyses reveal the potential significance of circadian pathways in cancer therapy

Background Circadian rhythm disturbance is an independent risk factor for cancer. However, few studies have been reported on circadian rhythm related genes (CRGs) in cancer, so it is important to further explore the impact of CRGs in pan-cancer.